Profil
A. Stewart Campbell currently works at Axial Therapeutics, Inc., as Chief Executive Officer & Director from 2021 and Synglyco, Inc., as Vice President-Research & Development from 2006.
Dr. Campbell also formerly worked at Insmed, Inc., as Director-Technical Operations, Surface Logix LLC, as Vice President-PreClinical Development, and Boehringer Ingelheim Corp., as Medicinal Chemist.
Dr. Campbell received his doctorate degree in 1992 from Queen's University and undergraduate degree in 1988 from St. Francis Xavier University.
Postes actifs de A. Stewart Campbell
| Sociétés | Poste | Début |
|---|---|---|
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Directeur Technique/Scientifique/R&D | 01/11/2006 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Directeur Général | 08/03/2021 |
Anciens postes connus de A. Stewart Campbell
| Sociétés | Poste | Fin |
|---|---|---|
| INSMED INCORPORATED | Directeur Technique/Scientifique/R&D | - |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Corporate Officer/Principal | - |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Corporate Officer/Principal | - |
Formation de A. Stewart Campbell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Surface Logix LLC
Surface Logix LLC Pharmaceuticals: MajorHealth Technology Manufactures molecular drugs | Health Technology |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Francis Xavier University
St. Francis Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotherapeutics | Health Technology |
















